scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11626-010-9274-6 |
P698 | PubMed publication ID | 20135358 |
P2093 | author name string | Weiguo Liu | |
Weiwei Hu | |||
P2860 | cites work | The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro | Q24564192 |
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype | Q29615563 | ||
ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristics | Q33508609 | ||
Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. | Q34005910 | ||
Long-term glioblastoma multiforme survivors: a population-based study. | Q34750725 | ||
Cancer stem cells in nervous system tumors | Q35892122 | ||
Stem cells in the etiology and treatment of cancer | Q36353139 | ||
Cancer stem cells and survival pathways | Q37141755 | ||
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts | Q39924899 | ||
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter | Q39942987 | ||
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. | Q40453744 | ||
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. | Q40904151 | ||
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells | Q42148487 | ||
In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors | Q42818740 | ||
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. | Q43636591 | ||
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma. | Q43761368 | ||
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase | Q45251720 | ||
Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or typ | Q45775557 | ||
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy | Q70147645 | ||
Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action | Q72585448 | ||
P433 | issue | 6 | |
P921 | main subject | suicide | Q10737 |
glioblastoma | Q282142 | ||
gene therapy | Q213901 | ||
P304 | page(s) | 497-501 | |
P577 | publication date | 2010-02-05 | |
P1433 | published in | In Vitro Cellular & Developmental Biology - Animal | Q1524094 |
P1476 | title | Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population | |
P478 | volume | 46 |
Q38841046 | Cancer suicide gene therapy: a patent review. |
Q98289803 | Complete regression of metastatic de-differentiated liposarcoma with engineered mesenchymal stromal cells with dTRAIL and HSV-TK |
Q39064497 | Enzyme/Prodrug Systems for Cancer Gene Therapy. |
Q37981990 | Flow cytometry in cancer stem cell analysis and separation |
Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
Q38262019 | Gene-directed enzyme prodrug therapy |
Q38003156 | Human ABCG2: structure, function, and its role in multidrug resistance. |
Q36527593 | The art of gene therapy for glioma: a review of the challenging road to the bedside |
Search more.